FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2298040877> ?p ?o ?g. }

• W2298040877 abstract "Amplified centrosomes are widely recognized as a hallmark of cancer. Although supernumerary centrosomes would be expected to compromise cell viability by yielding multipolar spindles that results in death-inducing aneuploidy, cancer cells suppress multipolarity by clustering their extra centrosomes. Thus, cancer cells, with the aid of clustering mechanisms, maintain pseudobipolar spindle phenotypes that are associated with low-grade aneuploidy, an edge to their survival. KIFC1, a nonessential minus end-directed motor of the kinesin-14 family, is a centrosome clustering molecule, essential for viability of extra centrosome-bearing cancer cells. Given that ovarian cancers robustly display amplified centrosomes, we examined the overexpression of KIFC1 in human ovarian tumors. We found that in clinical epithelial ovarian cancer (EOC) samples, an expression level of KIFC1 was significantly higher when compared to normal tissues. KIFC1 expression also increased with tumor grade. Our In silico analyses showed that higher KIFC1 expression was associated with poor overall survival (OS) in serous ovarian adenocarcinoma (SOC) patients suggesting that an aggressive disease course in ovarian adenocarcinoma patients can be attributed to high KIFC1 levels. Also, gene expression levels of KIFC1 in high-grade serous ovarian carcinoma (HGSOC) highly correlated with expression of genes driving centrosome amplification (CA), as examined in publically-available databases. The pathway analysis results indicated that the genes overexpressed in KIFC1 high group were associated with processes like regulation of the cell cycle and cell proliferation. In addition, when we performed gene set enrichment analysis (GSEA) for identifying the gene ontologies associated to KIFC1 high group, we found that the first 100 genes enriched in KIFC1 high group were from centrosome components, mitotic cell cycle, and microtubule-based processes. Results from in vitro experiments on well-established in vitro models of HGSOC (OVSAHO, KURAMOCHI), OVCAR3 and SKOV3) revealed that they display robust centrosome amplification and expression levels of KIFC1 was directly associated (inversely correlated) to the status of multipolar mitosis. This association of KIFC1 and centrosome amplification with HGSOC might be able to explain the increased aggressiveness in this disease. These findings compellingly underscore that KIFC1 can be a biomarker that predicts an aggressive disease course in ovarian adenocarcinomas." @default.
• W2298040877 created "2016-06-24" @default.
• W2298040877 creator A5001173182 @default.
• W2298040877 creator A5002940984 @default.
• W2298040877 creator A5003379676 @default.
• W2298040877 creator A5004697366 @default.
• W2298040877 creator A5008910507 @default.
• W2298040877 creator A5012761351 @default.
• W2298040877 creator A5019846100 @default.
• W2298040877 creator A5031181272 @default.
• W2298040877 creator A5079601307 @default.
• W2298040877 creator A5081186644 @default.
• W2298040877 creator A5081668848 @default.
• W2298040877 date "2016-03-18" @default.
• W2298040877 modified "2023-09-26" @default.
• W2298040877 title "A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas" @default.
• W2298040877 cites W1538500488 @default.
• W2298040877 cites W1794561752 @default.
• W2298040877 cites W1877106806 @default.
• W2298040877 cites W1893785507 @default.
• W2298040877 cites W1972807527 @default.
• W2298040877 cites W1979566241 @default.
• W2298040877 cites W1979765208 @default.
• W2298040877 cites W1997338647 @default.
• W2298040877 cites W2003027334 @default.
• W2298040877 cites W2026380718 @default.
• W2298040877 cites W2027795952 @default.
• W2298040877 cites W2036747263 @default.
• W2298040877 cites W2053476875 @default.
• W2298040877 cites W2064957458 @default.
• W2298040877 cites W2066969492 @default.
• W2298040877 cites W2071821824 @default.
• W2298040877 cites W2074083104 @default.
• W2298040877 cites W2075711878 @default.
• W2298040877 cites W2088561077 @default.
• W2298040877 cites W2090968329 @default.
• W2298040877 cites W2096283457 @default.
• W2298040877 cites W2105818146 @default.
• W2298040877 cites W2106493014 @default.
• W2298040877 cites W2121169754 @default.
• W2298040877 cites W2123696077 @default.
• W2298040877 cites W2128126810 @default.
• W2298040877 cites W2131593373 @default.
• W2298040877 cites W2133388973 @default.
• W2298040877 cites W2138903767 @default.
• W2298040877 cites W2140656629 @default.
• W2298040877 cites W2141569764 @default.
• W2298040877 cites W2147246240 @default.
• W2298040877 cites W2151325032 @default.
• W2298040877 cites W2153067045 @default.
• W2298040877 cites W2159195171 @default.
• W2298040877 cites W2169961966 @default.
• W2298040877 cites W2335887853 @default.
• W2298040877 cites W2412469771 @default.
• W2298040877 doi "https://doi.org/10.1186/s13048-016-0224-0" @default.
• W2298040877 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5477851" @default.
• W2298040877 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26992853" @default.
• W2298040877 hasPublicationYear "2016" @default.
• W2298040877 type Work @default.
• W2298040877 sameAs 2298040877 @default.
• W2298040877 citedByCount "40" @default.
• W2298040877 countsByYear W22980408772017 @default.
• W2298040877 countsByYear W22980408772018 @default.
• W2298040877 countsByYear W22980408772019 @default.
• W2298040877 countsByYear W22980408772020 @default.
• W2298040877 countsByYear W22980408772021 @default.
• W2298040877 countsByYear W22980408772022 @default.
• W2298040877 crossrefType "journal-article" @default.
• W2298040877 hasAuthorship W2298040877A5001173182 @default.
• W2298040877 hasAuthorship W2298040877A5002940984 @default.
• W2298040877 hasAuthorship W2298040877A5003379676 @default.
• W2298040877 hasAuthorship W2298040877A5004697366 @default.
• W2298040877 hasAuthorship W2298040877A5008910507 @default.
• W2298040877 hasAuthorship W2298040877A5012761351 @default.
• W2298040877 hasAuthorship W2298040877A5019846100 @default.
• W2298040877 hasAuthorship W2298040877A5031181272 @default.
• W2298040877 hasAuthorship W2298040877A5079601307 @default.
• W2298040877 hasAuthorship W2298040877A5081186644 @default.
• W2298040877 hasAuthorship W2298040877A5081668848 @default.
• W2298040877 hasBestOaLocation W22980408771 @default.
• W2298040877 hasConcept C104317684 @default.
• W2298040877 hasConcept C10447061 @default.
• W2298040877 hasConcept C121608353 @default.
• W2298040877 hasConcept C150173356 @default.
• W2298040877 hasConcept C2779672484 @default.
• W2298040877 hasConcept C2780427987 @default.
• W2298040877 hasConcept C29537977 @default.
• W2298040877 hasConcept C3019054536 @default.
• W2298040877 hasConcept C30481170 @default.
• W2298040877 hasConcept C40209533 @default.
• W2298040877 hasConcept C502942594 @default.
• W2298040877 hasConcept C54355233 @default.
• W2298040877 hasConcept C55493867 @default.
• W2298040877 hasConcept C86803240 @default.
• W2298040877 hasConcept C95444343 @default.
• W2298040877 hasConceptScore W2298040877C104317684 @default.
• W2298040877 hasConceptScore W2298040877C10447061 @default.
• W2298040877 hasConceptScore W2298040877C121608353 @default.
• W2298040877 hasConceptScore W2298040877C150173356 @default.
• W2298040877 hasConceptScore W2298040877C2779672484 @default.

• next